KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Net Margin (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Net Margin for 17 consecutive years, with 15.5% as the latest value for Q4 2025.

  • Quarterly Net Margin fell 6860.0% to 15.5% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 14.72% through Dec 2025, down 1723.0% year-over-year, with the annual reading at 14.72% for FY2025, 1723.0% down from the prior year.
  • Net Margin hit 15.5% in Q4 2025 for Abbott Laboratories, up from 14.46% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 84.1% in Q4 2024 to a low of 10.24% in Q4 2022.
  • Historically, Net Margin has averaged 18.38% across 5 years, with a median of 14.97% in 2024.
  • Biggest five-year swings in Net Margin: soared 6853bps in 2024 and later crashed -6860bps in 2025.
  • Year by year, Net Margin stood at 17.27% in 2021, then crashed by -41bps to 10.24% in 2022, then soared by 52bps to 15.56% in 2023, then skyrocketed by 440bps to 84.1% in 2024, then crashed by -82bps to 15.5% in 2025.
  • Business Quant data shows Net Margin for ABT at 15.5% in Q4 2025, 14.46% in Q3 2025, and 15.97% in Q2 2025.